王者荣耀观看直播赛事

Eli Lilly traded at $317.70 this Friday September 9th, increasing $2.20 or 0.70 percent since the previous trading session. Looking back, over the last four weeks, Eli Lilly gained 4.30 percent. Over the last 12 months, its price rose by 32.65 percent. Looking ahead, we forecast Eli Lilly to be priced at 292.65 by the end of this quarter and at 268.09 in one year, according to 王者荣耀电竞(江西)积分排榜 global macro models projections and analysts expectations.

Stock Price
317.70
Daily Change
0.70%
Yearly
32.65%

Ok
王者荣耀电竞(江西)积分排榜 members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The 王者荣耀电竞(江西)积分排榜 Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
AbbVie 141.42 0.90 0.64% 32.56%
Abbott 108.48 1.49 1.39% -15.78%
ALKERMES 24.01 -0.05 -0.21% -21.33%
Amgen 247.69 2.24 0.91% 15.88%
AstraZeneca 10,500.00 -12.00 -0.11% 28.47%
Astrazeneca 60.85 0.53 0.88% 8.16%
Baxter International 59.53 0.83 1.41% -26.43%
Biogen 211.84 3.86 1.86% -29.34%
Bristol-Myers Squibb 70.16 0.78 1.12% 11.14%
Coherus Biosciences 10.58 0.06 0.57% -31.25%
Catalent 95.97 2.70 2.89% -30.28%
Endo International 0.10 -0.01 -5.20% -96.28%
Gilead Sciences 65.28 0.18 0.28% -8.04%
GlaxoSmithKline 1,348.60 4.40 0.33% -5.00%
Glaxosmithkline 31.89 0.38 1.21% -19.77%
Horizon Pharma 66.09 4.06 6.55% -38.66%
Intercept Pharmaceuticals 17.00 -0.13 -0.76% 16.04%
Jazz Pharmaceuticals 152.66 1.11 0.73% 13.41%
J&J 165.71 0.32 0.19% -0.75%
Lannett 0.48 0.01 2.91% -85.03%
Eli Lilly 317.70 2.20 0.70% 32.65%
Medtronic 89.73 1.84 2.09% -31.58%
Merck & Co 87.34 -0.08 -0.09% 18.91%
Neurocrine Biosciences 106.51 -0.17 -0.16% 10.10%
Novartis 79.36 0.58 0.74% 0.88%
Novartis 82.60 1.34 1.65% -3.31%
Phibro Animal Health 15.09 0.21 1.41% -33.23%
Prestige Brands 52.12 0.53 1.03% -2.58%
Pfizer 47.84 0.76 1.61% 4.94%
Perrigo 39.15 0.55 1.42% -10.39%
Drreddys Laboratories 53.47 0.12 0.22% -18.92%
Regeneron Pharmaceuticals 724.32 15.47 2.18% 11.35%
Roche Holding 324.25 0.40 0.12% -5.74%
Revance Therapeutics 28.47 3.17 12.53% 4.98%
Sanofi 81.20 0.64 0.79% -0.82%
Sanofi 40.80 0.72 1.80% -15.56%
Teva Pharmaceutical Industries 9.17 0.17 1.89% -0.22%
United Therapeutics 223.48 -0.23 -0.10% 6.29%
Zoetis 164.31 5.82 3.67% -20.62%

Indexes Price Day Year
US500 4067 61.18 1.53% -8.77%

Eli Lilly
Eli Lilly and Company is a drug manufacturing company. The Company discover, develop, manufacture, and market products in a human pharmaceutical product segment. The Company’s products include Diabetes and other endocrinology products, including Baqsimi, Basaglar, Forteo, Humalog, Humatrope, Humulin, Jardiance, Trajenta and Trulicity. Its Immunology products include Olumiant and Taltz. Its Neuroscience products include Cymbalta, Emgality, Reyvow, Strattera and Zyprexa. Its Oncology products include Alimta, Cyramza, Erbitux and Verzenio. Other product includes Cialis, for the tratment of erectile dysfunction and benign prostatic hyperplasia. The Company manufacture and distribute its products through facilities in the United States, Puerto Rico, and 8 other countries. Its products are sold in approximately 120 countries.